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The proliferation and survival of hematopoietic stem cells (HSCs) has to be strictly coordinated to 
ensure the timely production of all blood cells. Here we report that the splice factor and RNA binding 
protein hnRNP L (heterogeneous nuclear ribonucleoprotein L) is required for hematopoiesis, since 
its genetic ablation in mice reduces almost all blood cell lineages and causes premature death of the 
animals. In agreement with this, we observed that hnRNP L deficient HSCs lack both the ability to self-
renew and foster hematopoietic differentiation in transplanted hosts. They also display mitochondrial 
dysfunction, elevated levels of γH2AX, are Annexin V positive and incorporate propidium iodide 
indicating that they undergo cell death. Lin-c-Kit+ fetal liver cells from hnRNP L deficient mice show 
high p53 protein levels and up-regulation of p53 target genes. In addition, cells lacking hnRNP L up-
regulated the expression of the death receptors TrailR2 and CD95/Fas and show Caspase-3, Caspase-8 
and Parp cleavage. Treatment with the pan-caspase inhibitor Z-VAD-fmk, but not the deletion of p53, 
restored cell survival in hnRNP L deficient cells. Our data suggest that hnRNP L is critical for the survival 
and functional integrity of HSCs by restricting the activation of caspase-dependent death receptor 
pathways.
In mice, hematopoiesis originates from hematopoietic stem cells (HSC) that migrate from the 
aorta-gonad-mesonephros region (AGM) towards the fetal liver (FL) at embryonal stage 10.5 day post-coitus 
and later on, takes place in the bone marrow (BM) of adult mice1,2. In both FL and BM, HSCs possess a unique 
self-renewal capacity and the potential to generate all mature blood and immune cells of an organism throughout 
its lifetime3–5. The commitment of HSCs to differentiate into specific cell lineages is tightly regulated and starts 
with the formation of multipotent progenitors (MPPs) that have a reduced self-renewal capacity and are already 
restricted in their multilineage potential6,7. The earliest precursors that emerge from MPPs still have both myeloid 
and lymphoid potential and are called LMPPs8,9.
HSCs reside in the BM or the FL and are part of the Lin−Sca1+cKit+ (LSK) subset. They can be further defined 
by the expression of the markers CD150 and CD48 (i.e. HSCs are Lin−Sca1+cKit+CD150+CD48−)10–13. While 
most HSCs in adult mice are in a quiescent stage, embryonic HSCs are proliferating to generate the adult pool 
of stem cells5,14,15. Many transcription factors including Runx1, Gfi1, Gfi1b, GATA2, SCL and Notch1 have been 
identified as important regulators of lineage commitment as well as HSCs quiescence and survival16–20. However, 
the role that mRNA processing factors may have for HSCs remains unexplored, even though they are known to 
control gene expression at the transcriptional and posttranscriptional level21,22.
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Heterogeneous nuclear ribonucleoprotein L (hnRNP L) is an RNA processing factor and an RNA-binding 
protein that has been identified to regulate alternative splicing by binding exonic splicing silencers elements (ESS) 
resulting in exon exclusion from the mature mRNA23–25. To investigate the role of hnRNP L in HSC function 
and hematopoietic differentiation, we have generated conditional hnRNP L knockout mice. Here, we present 
evidence that hnRNP L is essential for the survival and functional integrity of HSCs since ablation of this factor is 
incompatible with proper hematopoietic differentiation and causes premature and accelerated death in hnRNP L 
deficient animals. In particular, we report that hnRNP L deficient HSCs show increased mitochondrial stress and 
initiate both p53- and caspase-dependent cell death pathways.
Material and Methods
Ethics Statement. The protocols for the in vivo experiments described here were reviewed and approved 
by the Institut de recherches cliniques de Montréal (IRCM) Animal Care Committee (ACC); protocol numbers 
are: #2009-12/#2013-03. All animal experiments were conducted according to institutional rules put in place by 
the IRCM ACC, which follow the regulations and requirements of the Canadian Council on Animal Care (www.
ccac.ca).
Mice. hnRNP L floxed mice were described previously26. MxCre, VavCre, H2kBcl2 and Trp53−/− mice were 
obtained from Jackson laboratories or from a colony maintained at the IRCM. The animal ethics committee of the 
IRCM approved all animal experiments. MxCre+hnRNP Lfl/fl or hnRNP Lfl/fl mice were injected intraperitoneally 
with 500 μ g of polyinosinic-polycytidylic acid (pIpC; Sigma-Aldrich) every other day for a total of 5 times and 
were analyzed 14 days after the first injection. All mice were aged between 8–16 weeks for BM analysis.
Flow cytometric analysis and cell sorting. Cell surface staining was done using a lineage cocktail con-
taining antibodies against B220, Ter119, CD3, CD11b, Gr1, NK1.1, CD49b and CD8 that were all biotinylated 
and streptavidin labeled with a fluorescent dye (BD biosciences). Importantly, no antibody against CD11b was 
included in the lineage cocktail for FL cells. Antibodies against CD150, CD48, cKit, Sca1, CD34, Flt3, CD16/32, 
AA4.1, IL7R, Annexin V, CD95 and TrailR2 were either from BD biosciences, ebiosciences or Biolegends. 
Biotinylated Sca-1 antibody was included in the lineage cocktail mix when staining for myeloid progenitor cells. 
Hoechst staining and the analysis of reactive oxygen species (ROS) was performed as previously described17. 
Briefly, cells were first surface stained with specific markers and then incubated at 37 °C for 3 min with 5-(and-6)- 
carboxy-2′ ,7′ -dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA; Invitrogen) and analyzed by fluores-
cence activated cell sorting. Staining for phosphorylated H2AX was performed by fixing the cells with 2% para-
formaldehyde and by permealizing with PhosphoFlow buffer III (BD biosciences) for 20 min on ice. Cells were 
then stained with anti-γ H2AX (Cell signaling) followed by a FITC coupled anti-rabbit antibody. All analyses were 
done using a LSR FACS (BD biosciences). Mitochondria membrane potential was measured by fluorescence levels 
upon staining with Mitotracker green and Mitotracker deep red at 50 nM for 30 min at 37 °C, using an Invitrogen 
kit and performed according to the manufacturer’s instructions. LSK cells were sorted on a MoFlo cell sorter 
(Cytomation). Peripheral cells were stained with fluorescent conjugated antibodies against CD3, B220, CD19, 
Mac1, Gr1, Ter119, CD71 that were all from BD biosciences.
In vitro differentiation. OP9 or OP9DL1 cells were plated in AMEM with either IL-7 and SCF or IL-7, SCF, 
GM-CSF, IL-3 and IL-6 at a density of 2 × 104 cells in 24-well plates. Two thousand LSK cells from FL of E14.5 
embryos were sorted into each well. Cells were harvested 7 or 14 days later and were stained for CD4, CD8, CD19, 
Gr1 and Mac1.
Methylcellulose assay. Five hundred LSK cells sorted from E14.5 FL or BM were seeded on methycellulose 
(StemCell Technologies) supplemented with erythropoetin, IL-3, IL-6, SCF, transferrin and insulin. After 10 days, 
the number of colonies was determined.
Treatment with inhibitors. 5 × 104 Lin-FL cells from embryos E13.5 were sorted using an AutoMACS 
into StemSpan (StemCell Technologies) culture media supplemented with 2.6% FBS, L-Glutamine and SCF. The 
caspase-8 (Z-IETD-fmk) and Pan-caspase (Z-VAD-fmk) inhibitors were purchased from R&D Systems and used 
at a final concentration of 100 μ M. The ATM (KU-55933) and ATR (VE-822) inhibitors were purchased from 
Selleck Chemicals and used at a final concentration of 1nM. Cells were cultured for 24 hours before apoptosis 
rates were measured by annexin V staining (Annexin V-FITC Apoptosis Detection Kit; BD Pharmingen).
Transplantation assays. Non-competitive repopulation assays were performed using total FL cells from 
embryos E14.5 (2 × 105) or total BM (1 × 106). Competitive transplantation assays were done by pooling total 
BM cells from MxCre+hnRNPL Lfl/fl or MxCre+hnRNP Lwt/fl (CD45.2+) or FL cells from VavCre+hnRNP Lfl/fl or 
hnRNP Lwt/fl (CD45.2+) with BM cells from wt CD45.1+ mice at a 1:1 ratio for a total of 2 × 106 cells and 4 × 105, 
respectively. FL Lin−cKit+ progenitor cells transplant experiment was done by pooling 7,500 VavCre+hnRNP Lfl/fl 
or hnRNP Lwt/fl (CD45.2+) FL Lin−cKit+ progenitor cells with 1.5 × 105 carrier CD45.1+ FL cells. Cells from 
donor mice aged 8–12 weeks (one donor mouse per experiment) were injected intravenously into 9.6 Gy irradi-
ated syngeneic 8–12 week old CD45.1+ mice.
Real-time quantitative PCR. Total RNA was isolated from lineage depleted FL or BM cells using RNeasy 
Mini kit (Qiagen) according to the manufacturer’s instructions. cDNA was prepared from RNA using SuperScript 
II reverse transcriptase (Invitrogen) and was analyzed using TaqMan probes (Applied biosystems) and Gapdh 
as an internal control. A Mx-3005 system (Stratagene) was used and relative expression was calculated via the 
2−ΔΔCT method. QPCR was performed using a MasterMix for SYBR green (Quanta Biosciences) and a ViiA7 
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(Applied Biosystem). Melting curves were used to confirm the amplicon specificity. The exon usage was calcu-
lated via the Δ Δ CT (variable exon- constant exon) and the 2−ΔΔCT method. Primer sequences are provided in 
Supplementary Table 1.
RNA-Sequencing. RNA was extracted from sorted FL Lin−, c-Kit+ cells of E14.5 embryos using MagMAX™ -96 
Total RNA Isolation Kit. RNA integrity and quality were confirmed using a bioanalyzer (Agilent). Sequencing 
libraries were prepared from RNA extracts from three biological replicates using the TruSeq Stranded mRNA 
kit from Illumina according to the manufacturer’s instructions and sequenced using the TruSeq PE Clusterkit 
v3-cBot-HS on an Illumina HiSeq 2000 system. Sequencing reads were aligned to the GRCm38 Ensembl build of 
the genome using Tophat v2.0.1027. On average, each sample had 170350714 mapped reads with a standard devi-
ation of 21743591. For differential expression, reads were processed using Samtools28 and mapped to Ensembl 
transcripts using HTSeq29. Differential expression was tested using the DESeq R package and heatmaps were gen-
erated using the gplots R package30. Raw RNA-sequencing results and processed data are available on the Gene 
Expression Omnibus under accession GSE57875. The DAVID online tool was used to identify over-represented 
biological functions among genes significantly differentially expressed between hnRNPL KO vs. Wild-type sam-
ples31,32. The enrichment of selected biological functions of interest was also analyzed using the GSEA tool33.
Splicing Analysis. For the analysis of splice junctions, processed reads were mapped to exon junctions and 
differences between conditions were quantified using the MISO software34. For the analysis of Differential Exon 
Usage (DEU), reads were mapped to exons using Dexseq_count.py script and quantified using the DEXseq R 
package. These two analyses differ in that MISO focuses on sequencing reads spanning exon junctions while 
Differential Exon Usage focuses on relative differences in the abundance of reads within exons, thereby producing 
different results.
ChIP-qPCR. The detection of hnRNP L by ChIP was performed, as described previously35, on 5 × 106 NIH3T3 
cells cross-linked with 1% formaldehyde for 8 minutes and quenched with 125 mM glycine. Cells were lysed 
and chromatin was sonicated (Covaris E220 sonicator) to a size range of 200–500 bp. Samples were immuno-
precipitated with 5μ g anti-hnRNP L antibody (Ab32680; Abcam) or control anti-IgG antibody (sc-2025, Santa 
Cruz Biotechnology) coupled with Dynabeads beads coated with Protein G (Life Technologies). ChIP DNA was 
analyzed by quantitative PCR (qPCR) using SYBR green. The enrichment (relative to Input and a negative control 
intergenic region) was calculated using the Δ Δ Ct method. Primer sequences are provided in Supplementary 
Table 1.
Luciferase reporter assays. HEK293T cells were plated on 24-well plates at a density of 1 × 105 cells per 
well and, 24 h and 48 h later, transfected with 2pmol of siRNA using Lipofectamine 2000 as per the manufactur-
er’s instructions. At the 72 h time point, cells were transfected with both 250 ng the Trailr236 or control luciferase 
reporters and β -galactosidase, which was used to normalize luciferase values in each well. Firefly luciferase and 
beta-galactosidase activities were measured 24 h post-reporter transfection.
Actinomycin D assay. FL Lin− cells were sorted from E14.5 embryos into serum-free opti-MEM (Gibco). 
Cells were then treated with 5 μ g/mL actinomycin D at 37 °C and collected at 0, 2 and 4 hours post-treatment. 
Cells were lysed in RLT buffer with 10% β -mercaptoethanol and RNA was extracted using the Qiagen RNEasy 
Mini Kit, followed by RT-PCR and qPCR.
Statistical analysis. Two-tailed Student t test was used to calculate p values where indicated. A p value ≤ 0.05 
was considered statistically significant: * p ≤ 0.05, * * p ≤ 0.01, * * * p ≤ 0.001. Statistical analysis of survival curves 
was performed using the Log-rank test.
Results
Absence of hnRNP L results in altered hematopoiesis and premature death. Since constitutive 
deletion of hnRNP L arrests development before gastrulation, we had previously generated conditional knockout 
mice carrying floxed hnRNP L alleles26. To gain insight into the function of hnRNP L in hematopoietic stem and pro-
genitor cells (Figure S1a), we deleted the floxed alleles using a Vav-Cre transgene37. However, VavCre+hnRNP Lfl/fl 
mice were not viable and arrested development at embryonic stage E16.5-17.5 (Fig. 1a). To overcome this limi-
tation, hnRNP Lfl/fl mice were crossed with animals carrying the pIpC inducible Mx-Cre transgene, but an acute 
ablation of hnRNP L by pIpC injection also caused MxCre+hnRNP Lfl/fl mice to die quickly (Fig. 1b). Both the 
fetal liver (FL) of VavCre+hnRNP Lfl/fl mice and the bone marrow (BM) of adult MxCre+hnRNP Lfl/fl mice had a 
significantly reduced cellularity (Fig. 1c,d) accompanied by a reduction of lymphoid and erythroid cells in the FL 
and an almost complete loss of T cells from the fetal thymus (Fig. 1e). Analysis of peripheral blood of adult pIpC 
injected MxCre+hnRNP Lfl/fl mice also showed a decrease of differentiated cells including severe thrombocyto-
penia and neutropenia (Fig. 1f). This diminution was observed although the ablation of hnRNP L in adult BM 
was less efficient than in the FL (Figure S1b). These findings indicate that ablation of hnRNP L causes a severe 
disruption of hematopoiesis at very early stages, possibly at the level of hematopoietic stem cells.
Differential requirement of hnRNP L for fetal and adult HSCs and progenitors. Flow cytometric 
analysis revealed a significant reduction in frequencies and absolute numbers of common lymphoid and myeloid 
progenitors (CLPs, CMPs) and granulocytic monocytic progenitors (GMPs) and to a lesser extent of erythroid/
megakaryocytic precursors (MEPs) in both FL and BM of hnRNP L deficient mice compared to controls (Fig. 2a,b, 
Figure S1c–f). Furthermore, the LSK fraction was severely affected by the deletion of the hnRNP L gene (Figure S1g), 
but absolute numbers of HSCs (LSK, Flt3−CD150+CD48− cells) were maintained compared to controls (Fig. 2c). 
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Figure 1. Impaired hematopoiesis in the absence of hnRNP L. (a) Representative image of control (Lfl/fl) and 
VavCre+hnRNP Lfl/fl (L−/−) embryos at 14.5 days of embryonic development. (b) Survival curve of control and 
MxCre+hnRNP Lfl/fl mice injected five times with 500 μ g of pIpC. (c) Histogram showing absolute cell numbers 
of control and VavCre+hnRNP Lfl/fl embryos at E14.5 in whole FL or (d) MxCre+hnRNP Lfl/fl in total BM from 
two tibia and two femur bones. (n = 6 or more). (e) Flow cytometric analysis of lymphoid, erythroid and myeloid 
subsets in fetal thymus or FL from hnRNP Lfl/fl or VavCre+hnRNP Lfl/fl deleted embryos at E14.5. FACS plots 
are representative of three independent experiments. (f) Analysis of blood parameters from adult control or 
MxCre+hnRNP Lfl/fl mice performed using an Advia system (RBC: red blood cell, PLT: platelets, HGB: hemoglobin, 
WBC: white blood cells). (n = 6 or more). All error bars are means ± SEM (* p < 0.01, ** p < 0.001, *** p < 0.0001).
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However, in the BM of adult MxCre+hnRNP Lfl/fl mice, frequencies and absolute numbers of both HSCs and the 
MPP progenitors were significantly reduced compared to controls (Fig. 2d, Figure S1h). This suggests that hnRNP L 
is required to maintain the cellularity of phenotypically defined hematopoietic stem and progenitor populations, but 
also indicates that hnRNP L ablation has different effects in cells derived from FL or BM.
Figure 2. Impaired hematopoiesis and loss of progenitors and HSCs in FL and BM of hnRNP L deleted 
mice. (a) Absolute cell numbers of granulo-myeloid-erythroid progenitors GMP (defined as Lin−c-Kit+Sca-
1−CD34+CD16/32+), CMP (defined as Lin−c-Kit+Sca-1−CD34+CD16/32−) and MEP (defined as Lin−c-
Kit+Sca-1−CD34−CD16/32−). Shown are data from control mice (hnRNP Lfl/fl) or animals where hnRNP L 
was deleted in FL (VavCre+hnRNP Lfl/fl) or in adult BM (MxCre+hnRNP Lfl/fl) (n = 3 or more). (b) Absolute 
cell numbers of common lymphoid progenitor (CLP) in both FL (n = 5) and BM (n = 6) of control or hnRNP 
L deficient mice. (c) Absolute cell numbers of HSCs (defined as Lin−Sca1+c-Kit+ (LSK) Flt3−CD150+CD48−), 
MPP1 (defined as LSK Flt3−CD150+CD48+) and MPP2 (defined as LSK Flt3−CD150−CD48−) from FL control 
mice (hnRNP Lfl/fl) and VavCre+hnRNP Lfl/fl. (d) Absolute cell numbers of HSCs, MPP1 and MPP2 from BM of 
control mice (hnRNP Lfl/fl) and MxCre+hnRNP Lfl/fl (n = 3 or more). All error bars are means ± SEM (* p < 0.01, 
** p < 0.001, *** p < 0.0001).
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Figure 3. HSCs require hnRNP L to be functional. (a) Differentiation assays on OP9 and OP9-DL1 stromal 
cells; representative dot plots of myeloid cells (Gr1+Mac1+), B-cells (B220+CD19+) and T-cells (CD4+CD8+) 
differentiation of FL LSK cells from control (upper panel) and VavCre+hnRNP Lfl/fl mice (lower panel) (n = 3) 
(b) Colony assay on methylcellulose; 500 LSK cells from FL or BM from the indicated mice were seeded on 
methylcellulose and colonies were counted after 10 days of culture (n = 3). (c) Non-competitive transplantation 
assay: 2 × 105 FL cells of either VavCre+hnRNP Lfl/fl or control (hnRNP Lfl/fl) stage E14.5 embryos (both 
CD45.2+) were transplanted into irradiated syngenic CD45.1+ mice and the percentage of total CD45.2+ cells in 
the blood were measured at 4, 8 and 12 weeks post-transplantation. (d) The frequency of CD45.2+ cells within 
the T-, B-, myeloid or erythroid subpopulations (i.e. within CD3, B220, Gr1, Ter119 positive cells) in the blood 
of the recipient mice 12 weeks post-transplantation was assessed (n = 6). (e) Competitive transplantation assay: 
2 × 105 FL cells from VavCre+hnRNP Lfl/fl or VavCre+hnRNP Lwt/fl were mixed with 2 × 105 normal CD45.1+ 
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Phenotypically defined HSCs from hnRNP L deficient mice are functionally impaired. Using 
OP9 and OP9DL1 stroma co-cultures and methylcellulose assays, we found that hnRNP L deficient LSKs were 
unable to generate B- or T- lymphoid or myeloid cells in culture or any type of colony in semisolid medium, 
whereas wt LSKs efficiently gave rise to all three lineages and produced the expected number of colonies 
(Fig. 3a,b). Next, we transplanted non-competitively (Fig. 3c,d) or competitively (Fig. 3e,f) FL cells or trans-
planted FL Lin−cKit+ progenitor cells (Fig. 3g,h) from either wt or hnRNP L deficient embryos (CD45.2+) into 
irradiated syngeneic recipient mice (CD45.1+). Analysis of peripheral blood of the recipients showed that hnRNP 
L deficient cells were unable to generate detectable numbers of CD45.2+ cells upon transplantation, whereas 
transplanted control cells demonstrated a very efficient reconstitution of all lineages (Fig. 3d,f,h). Finally, we used 
cells from MxCre+hnRNP Lwt/fl or MxCre+hnRNP Lfl/fl mice and induced the deletion of hnRNP L in verified BM 
transplant chimeric mice after a competitive transplantation into syngeneic CD45.1+ mice (Figure S2a,b). Clearly, 
transplanted mice showed a strongly reduced percentage of CD45.2+ progenitors and HSCs after the deletion of 
hnRNP L alleles (Fig. 4a,b), suggesting that functional HSCs are almost entirely lost from hnRNP L deficient FL 
or BM.
Loss of hnRNP L leads to HSC apoptosis and mitochondrial stress. To gain further insight into 
the role of hnRNP L, we assessed cell cycle parameters and found a significant decrease in the percentage of 
G2/M-phase cells and a distinct increase in a sub-G1 fraction of hnRNP L deficient HSCs compared to wt HSCs 
(Fig. 5a). Both hnRNP L deficient fetal and adult HSCs and MPPs showed a higher frequency of Annexin V 
positive cells compared to wt controls (Fig. 5b,c), suggesting that hnRNP L deficient HSCs undergo apoptosis. 
The absence of hnRNP L also resulted in a loss of mitochondrial membrane potential in live FL and BM Lin- 
cells (Fig. 5d) as determined by using two mitochondria-specific labels that distinguish total (Mitotracker green) 
and respiring mitochondria (Mitotracker deep red). In addition, the level of reactive oxygen species (ROS) was 
elevated in hnRNP L deficient HSCs over controls (Fig. 5e). To assess whether apoptosis due to hnRNP L loss 
was primarily caused by mitochondrial dysfunction, fetal livers from VavCre+hnRNP Lfl/fl mice that also carry 
an anti-apoptotic H2k-Bcl-2 transgene were observed for frequencies of Annexin V positive cells. Surprisingly, 
over-expression of Bcl-2 did not reduce the level of Annexin V positive HSCs in VavCre+hnRNP Lfl/fl embryos 
(Figure S3a). Previous studies have reported a role for hnRNP L in preventing the decay of the mRNA encoding 
Bcl-238, but we did not find evidence that the deletion of hnRNP L affected the steady state expression level of 
Bcl-2 mRNA (Figure S3b). This excluded Bcl-2 mRNA stability or expression level as the cause of the increased 
apoptosis rates seen in hnRNP L deficient, Bcl-2 over-expressing HSCs.
High levels of mitochondrial ROS production are known to potentially cause DNA damage39. Indeed, we 
observed that hnRNP L deficient LSKs expressed elevated levels of phosphorylated H2AX (γ -H2AX), an indi-
cator of DNA double strand breaks (Fig. 5f). This suggests that a DNA damage response pathway is activated 
in hnRNP L deficient cells. However, treatment of hnRNP L deficient Lin− cells with KU-55933, an inhibitor 
of ATM, VE-822, an inhibitor of ATR, or both inhibitors simultaneously did not rescue the cells from dying as 
assessed by Annexin V and PI staining (Figure S4). This indicates that the observed cell death in hematopoietic 
cells lacking hnRNP L is not the sole result of DNA damage response-induced pathways.
Activation of p53 and p53-dependent pathways in hnRNP L null FL cells. To gain more insight 
into the molecular defects of hnRNP L deficient HSCs, we undertook a genome-wide analysis of mRNA expres-
sion and splicing through next-generation RNA sequencing using three independent preparations of wt or 
VavCre+hnRNP Lfl/fl E14.5 Lin−cKit+ FL cells (Fig. 6a). We first quantified splicing differences by mapping 
sequenced reads against all known annotated splice junction combinations within a gene locus, regardless of 
prior evidence of their usage in vivo. Surprisingly, this analysis did not reveal any significant differences in splicing 
between the wt and hnRNP L deficient cells. We also quantified variations in splicing through Differential Exon 
Usage (DEU) analysis, which only highlighted 38 genes having at least one exon with greater than 2-fold change 
in use (Table S2), after correction for transcript level changes. Functional analysis did not reveal any biological 
process significantly associated with these genes (Table S3). Notably, genes involved in apoptosis, such as Trp53, 
TrailR2 or FAS showed no significant DEU (Figure S5).
We next examined differentially expressed genes and observed that at a 2-fold threshold of up- or 
down-regulation, 470 genes were up-regulated and 88 genes were down-regulated in hnRNPL deficient cells. The 
genes down-regulated in their expression in hnRNP L deficient versus wt cells belonged mostly to GO categories such 
as hematopoietic differentiation and cell activation (Figure S5a,b). Notably, many genes important for HSC functions 
such as Gfi1, Runx1, Meis1, PU.1, CD34, Notch1 and Cxcr4, but also cytokine receptor genes, were affected (Figure 
S5c). The down-regulation of their expression in the absence of hnRNP L was confirmed by RT-qPCR (Figure S5d).
BM cells at a ratio of 1:1 for a total of 4 × 105 cells. The mixtures were transplanted into irradiated CD45.1+ 
recipient mice and the percentages of CD45.2+ cells in the blood were measured at 4, 8 and 12 weeks post-
transplantation. (f) The frequency of CD45.2+ cells within the T-, B-, myeloid or erythroid subpopulations (i.e. 
within CD3, B220, Gr1, Ter119 positive cells) in the blood of the recipient mice 12 weeks post-transplantation 
was assessed (n = 3). (g) 7.5 × 104 Lin−cKit+ progenitor cells from VavCre+hnRNP Lfl/fl or VavCre+hnRNP Lwt/
fl were mixed with 2 × 105 normal carrier CD45.1+ BM cells. The mixtures were transplanted into irradiated 
CD45.1+ recipient mice and the percentages of CD45.2+ cells in the blood were measured at 4, 8 and 12 
weeks post-transplantation. (h) The frequency of CD45.2+ cells within the T-, B-, myeloid or erythroid 
subpopulations (i.e. within CD3, B220, Gr1, Ter119 positive cells) in the blood of the recipient mice 12 weeks 
post-transplantation was assessed (n = 3). All error bars are means ± SEM.
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Figure 4. hnRNP L is required for HSCs and progenitor cells repopulation capacity. (a) Transplantation of 
total BM cells from MxCre+hnRNPLwt/fl or MxCre+hnRNPLfl/fl mice into irradiated syngenic CD45.1+ recipient 
mice. Ten weeks post-transplantation reconstitution was tested and mice were injected five times every other 
day with 500μ g of pIpC and analyzed 14 days later. The frequency of CD45.2+ cells and absolute cells numbers 
were quantified for progenitors and HSCs in the BM (n = 4). (b) Competitive transplantation of total BM cells 
from MxCre+hnRNPLwt/fl or MxCre+hnRNPLfl/fl mice mixed with wt CD45.1+ BM cells at a ratio of 1:1 for a 
total of 2 × 106 cells into irradiated syngenic CD45.1+ recipient mice and treated the same as the mice in A. 
(n = 4). All error bars are means ± SEM (* p < 0.01, ** p < 0.001, *** p < 0.0001).
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The most significant enrichment for the biological functions of up-regulated genes was found in a GO biologi-
cal process related to p53 (Fig. 6b) including many p53-target or -effector genes such as Cdkn1a, Tp53inp1, Zmat3 
or Ccng1, but also other genes involved in cell death such as CD95 and TrailR2 (Fig. 6c,d). Further functional 
assessment using GSEA confirmed enrichment of the p53 signaling and intrinsic apoptotic signaling pathways 
(Fig. 6b). To confirm that the RNA-Seq results represent actual expression differences in the FL subset, we val-
idated the expression changes of three of these genes (Cdkn1a, TrailR2 and Tp53inp1) by RT-qPCR using RNA 
from sorted LSK cells from hnRNP L deficient FL (Fig. 6e). Finally, analysis of p53 targets and effectors deregu-
lated in their expression in hnRNP L deficient cells confirmed that several p53 dependent pathways are affected 
by hnRNP L ablation (Figure S7). In agreement with this, we observed higher than control levels of p53 protein in 
hnRNP L deficient FL cells (Figure S8a), which was not accompanied by increased expression or half-life of p53 
mRNA (Figure S8b,c), suggesting that the deletion of hnRNP L does not affect p53 transcription directly.
Figure 5. Apoptosis induced by hnRNP L deletion in HSCs and progenitor cells. (a) HSCs (defined 
as LSK Flt3−, CD150+CD48−) from FL of animals with the indicated genotype were analyzed by Hoechst 
staining (upper panel). The percentages of cells in the different cell cycle phases are indicated by the gates in 
the histograms and the bar graph (lower panel). (n = 3). (b,c) Cell death was assessed by Annexin V staining 
in HSCs (defined as LSK Flt3−, CD150+CD48−), MPP1 (defined as LSK Flt3−, CD150+CD48+) and MPP2 
(defined as LSK Flt3−, CD150−CD48−) from FL (b) or BM (c), (n = 6) All error bars are means ± SEM (* p < 0.01, 
** p < 0.001, *** p < 0.0001). (d) FL or BM cells with the indicated genotype stained with Mitotracker green 
(total mitochondria) and Mitotracker deep red (respiring mitochondria) for 30 min and analysed by flow 
cytometry. (e) Level of reactive oxygen species (ROS) was assessed by flow cytometry using DHFCA staining on 
gated HSCs after incubation for 30 min at 37 °C. (n = 3) (f) Level of double strand breaks was assessed by flow 
cytometry using antibody against γ -H2AX on gated LSK (Lin−Sca-1+cKit+) population from FL or BM. Gray 
filled, isotype control; black line, control and red line, hnRNP L deleted cells (n = 3).
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Figure 6. Up-regulation of p53 protein and of genes associated with p53-dependent response in hnRNP 
L deficient cells. (a) Heatmap representation of genes significantly differentially expressed (> 2 fold change in 
expression, FDR < 0.05) between hnRNPL KO versus hnRNPL wt Lin−cKit+ samples. Genes of interest are 
highlighted. (b) Top: GO Biological processes identified as being over-represented among genes up-regulated 
in hnRNPL KO cells according to the DAVID software. Bottom: GSEA analysis confirming the enrichment of 
selected functions in the hnRNPL KO samples. Normalized Enrichment Score (NES) and nominal P-values are 
shown. (c) Fold increase in hnRNPL KO cells of selected genes of interest, as determined by RNA-Seq. Highlighted 
in bold are p53 target or effector genes. (d) Representation of RNA-Seq reads from hnRNPL WT (L fl/fl) and KO 
(L−/−) Lin−cKit+ samples on the p21 (CDKN1a), Trp53inp1 and TrailR2 loci. The y-axis shows reads per million 
aligned reads (RPM). (e) Validation of overexpression of selected genes from b) using RT-qPCR on flow sorted 
Lin−cKit+ cells from wt or hnRNP L deficient mice normalized relative to expression of Gapdh.
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To test whether the activation of a p53 pathway was responsible for the loss of cell functionality observed in 
hnRNP L deficient HSCs, we generated Vav-Cre, hnRNP Lfl/fl, p53−/− deficient mice. Frequencies or numbers of 
LSK cells in FLs of hnRNP L/p53 deficient animals were not significantly rescued (Figure S9a,b) and their ability 
to differentiate in an OP9 culture was not restored (Figure S9c), suggesting that other, p53-independent, cell death 
pathways must be active in hnRNP L deficient cells.
hnRNP L regulates TrailR2 expression and loss of hnRNP L induces cell death via caspase- 
dependent pathways. Death receptors CD95/Apo1/Fas and TrailR2 were found to be up-regulated in 
hnRNP L deficient cells (Fig. 6d–f). Although HSCs usually do not express CD9540, staining of hnRNP L defi-
cient HSCs from FL or BM revealed an abnormally high expression level of this death receptor compared to 
control cells (Figure S10). Similarly, HSCs from the FL or BM lacking hnRNP L were found to have higher levels 
of TrailR2 than wt control HSCs (Fig. 7a). To explore the possibility that hnRNP L could function as a tran-
scriptional regulator of the TrailR2 gene, we tested for hnRNP L binding by ChIP-qPCR over the TrailR2 locus. 
Data obtained with primers that cover the promoter region of TrailR2 indicate a direct or indirect occupation 
by hnRNP L principally at the transcription start site and within the first exon (Fig. 7b), suggesting that hnRNP 
L participates in the control of TrailR2 expression. To directly assess hnRNP L action on TrailR2 expression, a 
luciferase reporter construct carrying the TrailR2 promoter was transfected into HEK293 cells either expressing 
normal or reduced protein levels of hnRNPL upon transfection of a specific siRNA against hnRNP L (Fig. 7c, 
upper panel). Lower levels of hnRNP L significantly increased TrailR2 promoter activity (Fig. 7c, lower panel), 
suggesting that hnRNP L restricts TrailR2 transcription by binding to its promoter region.
Signaling through cell death receptors such as TrailR2 and Fas is known to induce cleavage of Caspase-8 
protein and further downstream effectors. Lin−cKit+ FL cells from hnRNP L deficient mice showed such cleaved 
forms of PARP1, Caspases-3 and -8 (Fig. 7d), suggesting that active signaling through cell death receptors takes 
place in hnRNP L deficient cells. Treatment of E14.5 hnRNP L deficient FL Lin− cells for 24 hours with Caspase-8 
specific inhibitor (Z-IETD-fmk), however, did not significantly reduce the number of Annexin V and PI positive 
cells (Fig. 7e). However, treatment with a Pan-Caspase inhibitor (Z-VAD-fmk) for 24 hours significantly reduced 
cell death from approximately 60% to 25% (Fig. 7e,f). This indicates that hematopoietic cell death due to an 
absence of hnRNP L is primarily mediated through Caspase-dependent pathways.
Discussion
Both the regulation of gene transcription and RNA metabolism play important roles in controlling the mainte-
nance of HSC self-renewal, survival and differentiation16–18,20. In this study, we set out to explore the role of the 
RNA binding protein and splicing factor hnRNP L and we present evidence that this factor is indeed critical for 
the functional integrity of HSCs and thus for normal hematopoiesis. The deletion of hnRNP L leads to the disrup-
tion of fetal and adult hematopoiesis and causes hematopoietic failure characterized by neutropenia, thrombocy-
topenia, anemia and premature death in adult mice. In addition, hnRNP L deficient, phenotypically defined HSCs 
were unable to elicit hematopoietic differentiation in transplanted hosts. These findings clearly establish hnRNP 
L as a novel regulator of hematopoiesis and an essential factor for hematopoietic stem cells. Unexpectedly, the 
data from our experiments suggest that hnRNP L exerts this function in hematopoietic stem- and progenitors, at 
least in part, as a regulator of transcription rather than acting as a splicing factor, a well described function of this 
protein in many other cell types and cell lines.
hnRNP L regulates cellularity of HSCs and is essential for their functional integrity. When phe-
notypically defined by staining for surface markers, HSCs seem to have differential requirements for hnRNP L 
depending on their developmental stage, since their numbers are clearly reduced in adult BM of hnRNP L defi-
cient mice, but are found at rather normal levels in hnRNP L deficient FLs. One possible explanation for this may 
be the fact that FL HSCs have a higher proliferative capacity than adult HSCs, which are almost all quiescent14,15. 
We cannot rule out that this is due to the use of different Cre alleles. However, both fetal and adult hnRNP L defi-
cient HSCs have lost all critical stem cell functions and, most importantly, their capacity to induce multi-lineage 
differentiation, shown by experiments such as differentiation on OP9 feeder layers and transplantation assays, 
very likely due to their high propensity to undergo cell death. In particular, our findings that hnRNP L deficient 
adult mice have less HSCs than wt mice can be explained by a higher rate of cell death, which was indeed con-
firmed by Annexin V and PI staining of progenitor cells suggesting that hnRNP L is required for their survival. 
Our RNA-Seq data confirm this notion since they show up-regulation of many cell death associated genes in 
hnRNP L deficient cells among them p53 effectors and genes for the death receptors and TNF family members 
CD95 and TrailR2.
Mitochondrial stress is activated in hnRNP L deficient cells. Our finding that loss of hnRNP L 
is associated with mitochondrial dysfunction is in agreement with previous reports that hnRNP proteins are 
involved both in nuclear RNA transcription and processing and also play important roles in mitochondria. 
High-throughput sequencing (CLIP-seq) in T cells to find RNA binding sites of hnRNP L revealed a significant 
number of transcripts aligned to mitochondrial DNA41. Additionally, hnRNP K, another member of the fam-
ily of RNA-binding proteins, has been shown to localize to the mitochondria and been co-purified with mito-
chondrial RNA42,43. It is thus conceivable that hnRNP L is essential for transcription and/or RNA processing in 
the ‘powerhouse of the cell’ and its loss leads to mitochondrial dysfunction. Compromised mitochondrial gene 
expression has previously been shown to elevate ROS production and reduce life span44. This is similar to the 
increased ROS levels we detected in hnRNP L null HSCs, which is a known activator of the DNA damage and 
p53-dependent pathways. However, mitochondrial stress is likely not the sole cause of cell death upon hnRNP L 
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Figure 7. Absence of hnRNP L results in activation of cell death pathways and eventually caspase-
dependent cell death. (a) TrailR2 expression was tested by flow cytometry on HSCs from FL of hnRNP Lfl/fl 
or VavCre+hnRNP Lfl/fl embryos and BM of hnRNP Lfl/fl or MxCre+hnRNP Lfl/fl mice. (b) Relative enrichment 
of hnRNP L over the TrailR2 promoter and intergenic control (Interg.) in 3T3 cells by ChIP-qPCR. Error bars 
represent standard deviation (n = 3). Schematic representation of primer locations over the TrailR2 gene locus. 
Arrow indicates the transcription start site (TSS) of TrailR2, medium thick line is the 5′ UTR, thickest line is 
exon 1 and the thinnest line is intron 1. (c) Luciferase assay for TrailR2 promoter region. HEK293T cells were 
transfected initially with scrambled or hnRNP L specific siRNA before transfection with the TrailR2 promoter 
reporter region or a control reporter construct. Luciferase activity was normalized to beta-galactosidase. Error 
bars represent the standard deviation (n = 3). P-values were calculated using the Student’s t-test. (d) Western 
blot analysis of PARP1 cleavage, Caspase-3 cleavage and Caspase-8 cleavage in total FL cells from hnRNP L wt 
embryos (Lfl/fl) and hnRNP L deleted embryos (L−/−). (e) Flow cytometry analysis of E14.5 FL lineage negative 
cells from indicated genotypes treated with Caspase-8 inhibitor (Z-IETD-FMK; 100 μ M), Pan-Caspase inhibitor 
(Z-VAD-FMK; 100 μ M) or DMSO as a negative control for 24 hours in culture before Annexin V and PI levels 
were measured. (n = 6) (f) Bar graph showing the significant quantification of the treated cells in e). All error 
bars are means ± SEM (* p < 0.01).
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loss since over-expression of the anti-apoptotic protein Bcl-2, which can counteract apoptosis due to mitochon-
drial dysfunction, did not restore cell survival in hnRNP L deficient cells.
DNA damage response pathways are activated in hnRNP L deficient cells. Both fetal and adult 
hnRNP L deficient HSCs showed increased levels of phosphorylated H2AX, which is one of the very first events 
subsequent to DNA damage45. It is possible that the increased levels of ROS are causing DNA damage and subse-
quently also the increase in H2AX phosphorylation, but it cannot be excluded that loss of hnRNP L also leads to 
genomic instability, replication stress and DNA damage as was reported for the hnRNP Npl346. Our RNA-Seq data 
are also in agreement with an ongoing DNA damage response in hnRNP L deficient cells since the up-regulation 
of p53 effectors and other genes that partake in a DNA damage response pathway is detected when hnRNP L is 
absent. However, the inability of ATM/ATR inhibitors to restore survival of hnRNP L null cells indicates that 
single and double stranded DNA breaks are not the only driver of cell death in the absence of hnRNP L.
Several data indicate that p53 plays a central role in the accelerated cell death of hnRNP L deficient HSCs. 
Most strikingly, the expression of p53 protein was drastically enhanced in hnRNP L deficient fetal liver cells. 
These high levels of p53 protein were not caused by a transcriptional up-regulation of the p53 gene as shown 
by RT-qPCR analysis nor by an altered half-life of the p53 mRNA. It is possible that hnRNP L regulates the 
translation efficiency of p53 possibly through direct binding to its mRNA as has been reported previously41,47. 
Alternatively, this activation of p53 may simply be the consequence of the ongoing DNA damage response in 
hnRNP L deficient cells. Both possibilities, however, would offer an explanation for the up-regulation of many 
DNA response genes and p53 target genes in hnRNP L deficient cells seen in the RNA-Seq analysis. Importantly 
though, p53 knockout was unable to rescue hnRNP L deficiency-induced cell death. This suggests that the activa-
tion of p53 is not the main cause of cell death in hnRNP L deficient cells but likely rather a consequence of DNA 
damage caused by elevated ROS levels or other yet unidentified stress signals in hnRNP L deficient cells.
hnRNP L controls the expression of death receptors and caspase-dependent cell death. Our 
RNA-Seq data indicate that both CD95 and TrailR2 (also called DR5) mRNAs are up-regulated in hnRNP L defi-
cient cells, suggesting that hnRNP L affects the transcriptional regulation of these genes. Indeed, our findings that 
hnRNP L is localized at the Trailr2 promoter region and that a TrailR2 promoter driven reporter gene is activated 
upon hnRNP L knockdown in cell lines clearly support this notion. It is therefore likely that hnRNP L controls 
death receptor signaling which is known to initiate several forms of cell death including apoptosis and necrop-
tosis. Our observation that the effectors of CD95/Fas/Apo1 and TrailR2, Caspases-3 and -8, as well as PARP1 are 
cleaved in hnRNP L deficient hematopoietic progenitor cells clearly indicates active death receptor signaling in 
hnRNP L deficient cells. Our findings that hnRNP L deficient cells show mitochondrial dysfunction, increased 
levels of ROS and activated p53 pathways would be in agreement with this, since death receptor signaling has 
previously been shown to cause loss of mitochondrial polarity48–50. Finally, our finding that Bcl-2 overexpression 
does not restore cell survival in hnRNP L deficient HSCs supports this notion, because death receptor/caspase-8 
cell death pathways can be initiated independently of Bcl-251.
The most unequivocal evidence that increased Caspase-dependent death receptor signaling is responsible 
for the cell death seen when hnRNP L is deleted comes from our experiment with pan-Caspase inhibitors. This 
treatment significantly restores the viability of hnRNP L deficient cells in culture, strongly suggesting that hnRNP 
L controls Caspase-dependent death pathways in hematopoietic stem and progenitors cells. This experiment 
also indicated that the form of cell death that is controlled by hnRNP L may be necroptosis rather than apop-
tosis, since almost all dying or dead cells from hnRNP L deficient mice have incorporated PI. Although this 
has to be confirmed by additional experiment, these data are in accordance with previous reports describing 
Caspase-dependent Trail- and FasL-induced necroptosis52,53 and other Caspase-dependent necrosis-like cell 
death pathways54,55.
Transcription, but not alternative splicing, is deregulated in hnRNP L null HSCs. It was surpris-
ing that our RNA-Seq analysis of hnRNP L deficient FL cells revealed altered regulation of mRNA expression lev-
els, but no differences in alternative splicing, since hnRNP L is a splicing factor and clear evidence support its role 
in the alternative splicing of many genes, most notably CD4524. In addition, we have previously reported that con-
ditional deletion of hnRNP L using the same animals as in this study affects alternative splicing in T-cells notably 
the CD45 pre-mRNA26 confirming this well-established function of hnRNP L. However, the biological functions 
of hnRNP L and their cell type specificity have not been fully clarified yet and it is possible that hnRNP L is also 
involved in transcriptional regulation. A few reports have already provided evidence for such a role; for instance, 
hnRNP L was found to be required for transcription of the TNFalpha gene46 and has also been associated with 
the mediator complex associated with transcription initiation and elongation56,57. Our data with the TrailR2 gene 
lend further support to the idea that hnRNP L also regulates transcription and not only alternative splicing. The 
published reports, along with our results, suggest that hnRNP L may be involved in several different aspects of 
regulating mRNA transcription and splicing, which may be highly context dependent or restricted to specific cell 
types. It is however also possible that fully deleted HSCs are rapidly lost and that cells with incomplete deletions of 
hnRNP L containing residual hnRNP L protein remain in the analysis and obscure the RNA-Seq analysis making 
a detection of alternative splicing events difficult. This would not be surprising given that several cell death path-
ways are activated and numbers of functional HSCs are strongly decreased in hnRNP L deficient animals. Overall, 
our findings provide compelling evidence that hnRNP L is a novel regulator essential for survival and functional 
integrity of HSCs and thereby for hematopoietic differentiation, acting by controlling Caspase-dependent cell 
death pathways.
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